Limited coverage criteria – ciprofloxacin ophthalmic

Last updated on February 28, 2025

Generic name

ciprofloxacin ophthalmic

Strength & form

0.3% eye drop
 

Special Authority criteria

Approval period

Failure or intolerance to first-line agents. (e.g., aminoglycosides)

Short term

Practitioner exemptions

Practitioners in the following specialty are not required to submit a Special Authority request form for coverage:

  • Ophthalmologists

Special notes

  • None

Special Authority request form